Visium Asset Management’s Pfizer PFE Stock Holding History

Visium Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-53,859	Closed	-$1.51M	–	453
2016 Q1	$1.51M	Buy	+53,859	New	+$1.54M	0.03%	410

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Visium Asset Management's PFE Position: Q3 2016 in Review

Visium Asset Management sold out of Pfizer (PFE) in Q3 2016, closing a stake of 7,378 shares — an estimated $247K sold.

Visium Asset Management first reported a position in PFE in Q2 2013 and held it in 11 quarters. The position peaked at $63.6M in Q1 2016. 1,964 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

Visium Asset Management reported no remaining Pfizer position as of Q3 2016 after selling out during the quarter.
Visium Asset Management sold 7,378 Pfizer shares in Q3 2016, an estimated $247K.
Visium Asset Management first reported a position in Pfizer in Q2 2013 and held it in 11 quarters.
Visium Asset Management's Pfizer position peaked at $63.6M in Q1 2016.
1,964 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Visium Asset Management's 13F filing for Q3 2016.